Louisiana Patients Could Lose Access to GLP-1 Weight-Loss Drugs as Coverage Vanishes Highlights Louisiana state employees are already prohibited from using GLP-1s for weight loss despite $200 million annual spending on diabetes coverage Over 41 million Americans lost commercial insurance coverage for Wegovy in 2026, with major insurers eliminating coverage nationwide Four states, including California and Pennsylvania, eliminated Medicaid coverage for obesity treatment between October 2025 and January 2026 Louisiana Medicaid provides limited coverage for one non-GLP-1 weight-loss drug but restrictions remain tight Patients face monthly costs ranging from $936 to $1,349 without insurance coverage BATON ROUGE, La
I see so many patients who come in, and they say things like, Ive lost all this weight, and Im ready to own my body, own my face, and own my experience in a very different way, Dr
How does PlexusDx personalize tirzepatide for my body
Capasso 2013
For the semaglutide/B12 combination, you might see "5mg/500mcg/1mL" which tells you the vial contains 5 mg of semaglutide and 500 mcg of B12 per each milliliter of solution